- Home
- CENN vs ANTX Comparison
CENN vs ANTX Comparison
Compare CENN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- ANTX
- Stock Information
- Founded
- CENN 2013
- ANTX 2017
- Country
- CENN United States
- ANTX United States
- Employees
- CENN N/A
- ANTX N/A
- Industry
- CENN Auto Manufacturing
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- CENN Consumer Discretionary
- ANTX Health Care
- Exchange
- CENN Nasdaq
- ANTX Nasdaq
- Market Cap
- CENN 30.4M
- ANTX 33.2M
- IPO Year
- CENN N/A
- ANTX 2022
- Fundamental
- Price
- CENN $0.64
- ANTX $1.09
- Analyst Decision
- CENN
- ANTX Buy
- Analyst Count
- CENN 0
- ANTX 2
- Target Price
- CENN N/A
- ANTX $2.00
- AVG Volume (30 Days)
- CENN 695.7K
- ANTX 92.7K
- Earning Date
- CENN 08-12-2025
- ANTX 08-12-2025
- Dividend Yield
- CENN N/A
- ANTX N/A
- EPS Growth
- CENN N/A
- ANTX N/A
- EPS
- CENN N/A
- ANTX N/A
- Revenue
- CENN $31,097,533.00
- ANTX N/A
- Revenue This Year
- CENN N/A
- ANTX N/A
- Revenue Next Year
- CENN N/A
- ANTX N/A
- P/E Ratio
- CENN N/A
- ANTX N/A
- Revenue Growth
- CENN 234.45
- ANTX N/A
- 52 Week Low
- CENN $0.61
- ANTX $0.87
- 52 Week High
- CENN $1.77
- ANTX $2.98
- Technical
- Relative Strength Index (RSI)
- CENN 40.79
- ANTX 52.20
- Support Level
- CENN $0.61
- ANTX $1.05
- Resistance Level
- CENN $0.66
- ANTX $1.10
- Average True Range (ATR)
- CENN 0.05
- ANTX 0.03
- MACD
- CENN -0.00
- ANTX 0.01
- Stochastic Oscillator
- CENN 19.28
- ANTX 83.50
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.